NEXT Oncology, founded by internationally known cancer researcher Dr. Anthony Tolcher, has entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain. The venture increases global access to new agents and anticancer therapies for cancer patients. View the full article at Let Life Happen
Understanding your risk for breast cancer key to getting treatment
A local oncologist talks about a group that’s at higher risk of dying from breast cancer. View the video at KSAT.com
Sharon Wilks joins NEXT Oncology’s phase I clinical investigation team
Sharon Wilks joined NEXT Oncology’s phase I clinical investigation team, bringing more than 30 years of research and clinical experience to the practice. View the full article at the Cancer Letter
Meet NEXT Oncology’s Founder, Dr. Anthony Tolcher
Dr. Anthony Tolcher has spent nearly 40 years looking after patients, and today his compassion and drive to care for patients remains as strong as the day he graduated from medical school. With a targeted interest in the development of new anticancer agents and a focus in molecular genetic targets for cancer therapy, Dr. Tolcher founded NEXT Oncology with a …
NEXT Oncology Adds Dr. Sharon Wilks to Phase I Clinical Investigation Team
Wilks to focus on advancements in novel therapies for breast cancer (SAN ANTONIO) December 8, 2021 –– Medical oncologist Dr. Sharon Wilks joins NEXT Oncology bringing more than 30 years of research and clinical experience to the practice. NEXT Oncology’s Phase I oncology centers provide patients with advanced cancer access to the newest treatments available. Dr. Wilks focuses on research …